Shilajit is a mineral-rich resin containing fulvic acid that enhances mitochondrial electron transport, boosts testosterone in deficient men, and may slow tau aggregation. Purified resin or standardized extract at 250–500 mg/day is the most clinically supported form — but sourcing quality matters enormously given heavy metal contamination risks.

Shilajit is a sticky substance that oozes from Himalayan rocks, formed over thousands of years as plants decompose. It contains a special compound called fulvic acid that helps your cells make energy more efficiently, supports healthy testosterone, and may protect brain cells. Think of it as a concentrated mineral and antioxidant package from the mountains.

At a Glance

Feature	Details
Primary compound	Fulvic acid (40–60% in purified extract), humic acid, dibenzo-α-pyrones
Mechanism	Mitochondrial electron transport facilitation, CoQ10 recycling, testosterone biosynthesis support
Clinical dose	250–500 mg/day purified resin or standardized extract (≥50% fulvic acid)
Time to effect	4–8 weeks for hormonal shifts; 2–4 weeks for subjective energy
Key safety concern	Heavy metal contamination in raw/unpurified products
Contraindications	Active gout (raises uric acid), hemochromatosis, pregnancy
Best combined with	CoQ10, zinc, magnesium, ashwagandha
Evidence grade	Moderate — human RCTs for testosterone; preclinical for neuroprotection

Shilajit occupies an unusual position in integrative medicine: it is ancient enough to appear in Sanskrit texts but modern enough to have randomized controlled trials examining its molecular mechanisms. Formed over millennia through the slow decomposition of plant matter compressed in Himalayan, Altai, and Caucasian rock strata, this blackish-brown resinous exudate delivers a concentrated matrix of fulvic acid, humic substances, dibenzo-α-pyrones (DBPs), and more than 80 trace minerals. The clinical question is not whether shilajit is bioactive — the evidence is clear that it is — but which patient populations benefit most and under what conditions the risk-benefit calculation favors its use.

What Is Shilajit? The Biochemistry of an Ancient Resin

The name derives from Sanskrit: shila (rock) and jatu (lac or exudate). Traditional Ayurvedic physicians classified it as a rasayana — a rejuvenating substance that promotes longevity. Modern analytical chemistry has begun explaining why.

Shilajit’s bioactivity depends on three overlapping compound classes:

Fulvic acid is the dominant active constituent and the reason most standardized extracts are graded by fulvic acid percentage. Fulvic acid is a low-molecular-weight humic substance capable of crossing cellular membranes. It functions as an electron shuttle, accepts and donates electrons in oxidation-reduction reactions, chelates minerals to improve absorption, and modulates inflammatory signaling via NF-κB inhibition.

Dibenzo-α-pyrones (DBPs) are oxygenated heterocyclic compounds unique to shilajit. They act synergistically with fulvic acid in mitochondrial electron transport and appear to be the compounds responsible for CoQ10 recycling from ubiquinone back to ubiquinol — the active reduced form.

Humic acid and trace minerals provide a background matrix of zinc, iron, copper, manganese, magnesium, and selenium in naturally chelated forms that may improve bioavailability compared with inorganic mineral salts. However, this mineral richness is also the source of the contamination concern: unprocessed or poorly purified shilajit can carry arsenic, lead, and mercury at clinically significant concentrations.

Fulvic Acid and the Mitochondrial Connection

The most pharmacologically compelling aspect of shilajit is its interaction with Complex I and Complex II of the mitochondrial electron transport chain. Fulvic acid’s structure allows it to shuttle electrons between NADH and the ubiquinone pool, while DBPs appear to regenerate ubiquinol from ubiquinone — effectively extending the active lifespan of CoQ10 molecules already present in the inner mitochondrial membrane.

This mechanism has practical implications for patients who complain of persistent fatigue, post-exertional malaise, or “brain fog.” When mitochondrial electron flow is inefficient — whether from aging, chronic illness, or toxic burden — cellular ATP production drops and reactive oxygen species increase. Shilajit’s fulvic acid addresses this at the membrane level rather than simply providing precursors.

A double-blind, placebo-controlled trial by Surapaneni et al. demonstrated that shilajit supplementation at 200 mg twice daily significantly attenuated fatigue markers and improved maximal muscular strength output in recreationally active males over 8 weeks (PMID: 22557127). A separate investigation by Keller et al. (2019) found that 500 mg/day preserved muscular strength during high-volume exercise compared with placebo — an effect attributed to mitochondrial preservation rather than anabolic signaling per se.

From a clinical standpoint, I find shilajit most useful in the context of:

Post-viral fatigue (including long COVID and EBV reactivation), where mitochondrial dysfunction is increasingly documented
Age-related fatigue in patients over 45 with suboptimal CoQ10 status
Patients on statins, whose mitochondrial CoQ10 is further depleted by HMG-CoA reductase inhibition

In these populations, shilajit combined with ubiquinol CoQ10 at 100–200 mg/day provides complementary mechanisms — shilajit facilitating electron shuttling, ubiquinol providing the substrate.

Testosterone, Hormonal Balance, and Reproductive Health

The most extensively studied human application of shilajit relates to testosterone and male reproductive health. A landmark randomized, double-blind, placebo-controlled study by Pandit et al. (2016) enrolled 96 infertile males and administered 200 mg purified shilajit twice daily for 90 days. The treatment group showed significant increases in total sperm count (61.4%), motility, and testosterone levels (23.5% increase in total testosterone) compared to placebo (PMID: 26830110).

A subsequent study by Sengupta et al. (2013) in healthy volunteers aged 45–55 confirmed that 250 mg twice daily for 90 days significantly increased total testosterone, free testosterone, and dehydroepiandrosterone (DHEAS) while also showing a trend toward reduced follicle-stimulating hormone (FSH) — a pattern consistent with improved Leydig cell function rather than gonadotropin suppression (PMID: 23667832).

The mechanisms proposed include:

Leydig cell stimulation — fulvic acid appears to increase luteinizing hormone (LH) receptor sensitivity
Oxidative protection of steroidogenic enzymes — the antioxidant properties of fulvic acid protect mitochondria in Leydig cells, where cholesterol-to-pregnenolone conversion occurs
Zinc bioavailability — shilajit’s naturally chelated zinc may support 5-alpha reductase activity and testosterone biosynthesis

Clinical context: I interpret these findings as most applicable to men with documented hypogonadism or suboptimal testosterone in the 300–450 ng/dL range who are not yet candidates for testosterone replacement therapy. Shilajit is not a substitute for TRT when clinically indicated, but it represents a reasonable first-line intervention in men with borderline levels, particularly when fatigue and reproductive concerns coexist.

For women, the evidence base is substantially thinner. Theoretically, shilajit’s DHEAS-elevating effect could support adrenal hormone production in women with HPA axis dysregulation, and the mitochondrial mechanisms apply equally. However, I currently use it cautiously in women and only in those with confirmed low DHEAS or fatigue syndromes where adaptogens are already part of the protocol.

Cognitive Protection and Neuroprotection

Perhaps the most intriguing emerging application of shilajit is its potential to modulate neurodegenerative pathways. Fulvic acid has been shown in vitro to inhibit the aggregation of tau protein filaments — the neurofibrillary tangles that characterize Alzheimer’s disease pathology. A study by Cornejo et al. (2011) demonstrated that fulvic acid not only prevented tau filament formation but promoted disaggregation of existing fibrils at physiologically achievable concentrations (PMID: 21696922).

Separately, a review by Carrasco-Gallardo et al. (2012) documented shilajit’s potential as a “natural phytocomplex with potential procognitive activity,” synthesizing evidence across cholinergic pathway support, anti-inflammatory mechanisms, and mitochondrial protection in neuronal tissue (PMID: 22482077).

DBPs in shilajit also appear to support BDNF (brain-derived neurotrophic factor) expression — an effect that overlaps with the mechanisms of other adaptogens like lion’s mane and rhodiola, though the pathways differ.

In clinical practice, I most frequently discuss shilajit in the context of cognitive support when patients present with:

Subjective cognitive decline with documented mitochondrial markers (elevated lactate, low ATP production on OAT)
Post-COVID cognitive impairment where neuroinflammation and mitochondrial dysfunction overlap
Patients seeking adjunctive support alongside established nootropics

It is important to maintain appropriate humility here: the tau disaggregation and BDNF findings are predominantly preclinical. Human trials demonstrating cognitive outcomes are not yet available. Shilajit should be framed as a supportive intervention, not a primary cognitive therapeutic.

Clinical Dosing, Forms, and Quality Considerations

Recommended dose: 250–500 mg/day of purified shilajit resin or standardized extract standardized to ≥50% fulvic acid. The lower dose (250 mg) is appropriate for general supplementation; 500 mg/day was used in testosterone trials and is the upper end of routine clinical use.

Forms ranked by quality:

Purified resin — the traditional form, typically dissolved in warm water or milk. Highest fulvic acid concentration and most authentic mineral matrix. Requires a trusted, tested supplier.
Standardized extract (powder or capsule) — allows dosing precision and quality verification. Look for third-party testing for heavy metals, fulvic acid percentage certification, and preferably GRAS status.
Liquid fulvic acid drops — these contain fulvic acid in isolation without DBPs and the full mineral complex. Mechanistically incomplete compared to whole shilajit.
Raw/unpurified shilajit — not recommended. Contamination with lead, arsenic, and mycotoxins has been documented repeatedly in unprocessed product.

Timing: Morning with food. Some practitioners recommend cycling — 8 weeks on, 2 weeks off — though this is based on traditional Ayurvedic practice rather than pharmacokinetic data.

Stacking: Shilajit synergizes well with:

CoQ10 (ubiquinol form) — complementary mitochondrial support
Zinc — testosterone biosynthesis pathway
Ashwagandha — additive adaptogenic effect on cortisol and HPA axis
Magnesium glycinate — cellular energy and sleep quality

Safety, Contraindications, and What to Watch For

Purified shilajit has a favorable safety profile when sourced from reputable suppliers. However, several concerns warrant attention:

Heavy metal contamination remains the dominant safety concern. A 2012 analysis found that commercial shilajit products varied enormously in lead and arsenic content. The FDA has issued warnings on specific brands. Patients should be advised to use only products with published Certificates of Analysis including ICP-MS heavy metal testing.

Uric acid elevation: Shilajit has been reported to modestly increase uric acid levels. Patients with gout, hyperuricemia, or a history of uric acid kidney stones should use caution and monitor uric acid at baseline and after 6–8 weeks.

Iron loading: In patients with hemochromatosis or other iron overload conditions, shilajit’s iron content and potential to enhance iron absorption is a meaningful concern.

Drug interactions: Theoretical interaction with anticoagulants (fulvic acid has mild blood-thinning properties), thyroid medications (mineral chelation could affect levothyroxine absorption if taken together), and iron supplementation (additive iron loading).

Pregnancy and breastfeeding: Insufficient safety data. Avoid.

From a monitoring standpoint, I recommend checking a baseline complete metabolic panel, uric acid, and heavy metals panel (particularly lead and arsenic) if patients intend to use shilajit long-term. Repeating these at 3 months allows early identification of any adverse shift.

Where Shilajit Fits in a Comprehensive Protocol

Shilajit is not a standalone intervention. Its place in a functional medicine protocol depends heavily on the clinical picture:

Fatigue + mitochondrial markers → shilajit + ubiquinol + B-complex (especially riboflavin and niacinamide)
Borderline testosterone + reproductive concerns → shilajit + zinc + ashwagandha + lifestyle optimization
Cognitive support protocol → shilajit + lion’s mane + phosphatidylserine + DHA
Post-viral recovery → shilajit within a broader mitochondrial support protocol alongside NAD+ precursors and antioxidants

The mineral density and fulvic acid content make shilajit particularly useful in patients who present with multi-system fatigue and diffuse mineral insufficiency — a pattern I see frequently in patients with chronic infections, mold illness, or prolonged stress who have been eating a narrow or processed diet.

References

Pandit S, et al. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016;48(5):570–575. PMID: 26830110
Sengupta P, et al. A double blind, placebo controlled study of the effects of Shilajit on testosterone levels in healthy volunteers. Phytotherapy Research. 2013;27(9):1362–1366. PMID: 23667832
Surapaneni DK, et al. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats. Journal of Ethnopharmacology. 2012;143(1):91–99. PMID: 22557127
Carrasco-Gallardo C, et al. Shilajit: A natural phytocomplex with potential procognitive activity. International Journal of Alzheimer’s Disease. 2012;2012:674142. PMID: 22482077
Cornejo A, et al. Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer’s disease. Journal of Alzheimer’s Disease. 2011;27(1):143–153. PMID: 21696922
Bhattacharyya S, et al. Shilajit dibenzo-α-pyrones: mitochondria targeted antioxidants. Pharmacologyonline. 2009;2:690–698.
Keller JL, et al. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. Journal of the International Society of Sports Nutrition. 2019;16(1):3. DOI: 10.1186/s12970-019-0270-2